Seroprotection Status of Hepatitis B Vaccine in Children with Type 1 Diabetes Mellitus
Background:"Type 1 diabetes mellitus [T1DM]" is the most common endocrine disease in the Pediatric population. It has been suggested that T1DM had inadequate immunological response to vaccines, including hepatitis B virus [HBV] vaccine. Aim of the Work:To evaluate the immunological status...
Enregistré dans:
Auteurs principaux: | Dina Elsharkawy, Hany Abd Elhady El-khaleegy, Saad Mohamed, Gamal Mohamed |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Al-Azhar University, Faculty of Medicine (Damietta)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bd25e20f301749aaa7ddd3b95d8ead09 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
COMPARING HEPATITIS B SEROPROTECTION IN PAKISTANI CHILDREN AT 5 AND 6 YEARS OF AGE AFTER EXPANDED PROGRAMME ON IMMUNIZATION (EPI) VACCINATION
par: Ehsan Qadir, et autres
Publié: (2020) -
IMMUNOGENICITY OF THE THIRD GENERATION HEPATITIS B VACCINE (pre-S1/pre-S2/S)
par: E. V. Esaulenko, et autres
Publié: (2018) -
Hepatitis B vaccination status and associated factors among university students in Ghana: A cross-sectional survey
par: Akwasi Adjei Gyimah, et autres
Publié: (2021) -
Markers for hepatic autoimmune disorders in patients with type 1 diabetes mellitus
par: Olga Sergeevna Derevyanko, et autres
Publié: (2014) -
Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
par: Percy A. Knolle, et autres
Publié: (2021)